Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164437 · ClinicalTrials.gov registry record · Phase 2
CD-ROM Intervention for Prostate Cancer Screening
A Phase 2 study of Prostate Cancer, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 554
- Enrollment target
- 1
- Study location
NCT00164437 is a Phase 2 study of Prostate Cancer that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 554 participants, roughly in line with the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00164437, a Phase 2 study of Prostate Cancer, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 554 participants
- Enrollment target
- 1
- Study location
Study Summary
The study populations consist of a sample of the patient population (men aged 40-79 years) of a large, group model HMO and a community sample of men age 50-79. Follow-up interviews of men randomly assigned to the intervention and control groups are being conducted by telephone to assess issues related to prostate cancer screening and the men's use of the CD-Rom educational intervention.
Conditions Studied
Interventions
- BEHAVIORAL educational CD-ROM
Study Locations (1)
Colorado
- University of Colorado Health Sciences Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 554 participants |
| Start Date | 2002-09 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00164437
The ClinicalTrials.gov registry entry for NCT00164437 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 554 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which educational CD-ROM is the first listed.
NCT00164437 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT00164437 about?
NCT00164437 is a clinical study titled "CD-ROM Intervention for Prostate Cancer Screening". The study populations consist of a sample of the patient population (men aged 40-79 years) of a large, group model HMO and a community sample of men age 50-79. Follow-up interviews of men randomly assigned to the intervention and control groups are being conducted by telephone to assess issues relat...
What is the current status of trial NCT00164437?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 554 participants. The study started on 2002-09. Estimated completion is 2004-09.
What conditions does trial NCT00164437 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00164437?
The interventions under investigation include: educational CD-ROM (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164437?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00164437 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
RECRUITING · Phase 2
-
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
RECRUITING · Phase 2
-
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
RECRUITING · Phase 2
-
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
RECRUITING · Phase 2
-
High Intensity Focused Ultrasound in Prostate Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.